Market Scenario:
Type 2 diabetes mellitus is a metabolic disorder which results
from an excess of caloric intake over energy expenditure. The condition is
characterized by progressive insulin secretory defect, which increases the
body’s demand for insulin in order to retain glucose homeostasis. Hyperglycemia
is a major symptom of type 2 diabetes mellitus. According to the National
Diabetes Statistics Report suggested by CDC, it is found that 9.4% of the U.S.
population, i.e. 30.3 million people had diabetes in 2015. Various other
factors such as growing awareness, huge research funding in diabetes diagnosis
and treatment, unmet medical needs, increasing global prevalence of obesity,
improving regulatory framework, increasing government assistance, and
increasing adoption rate, are continuously contributing to the growth of the global
type 2 diabetes mellitus treatment market.
Despite these drivers, there are some issues associated with
type 2 diabetes mellitus treatment market. The high cost associated with
diagnosis and treatment of diabetes, side effects of available treatment options,
and poor healthcare system in low and middle-income countries may hamper the
growth of the market to an extent.
It is estimated that the type 2 diabetes mellitus treatment
market is expected to grow at a CAGR 8.0% during the forecast period of 2017-2023.
Segmentation:
On the basis of the treatment, the market is classified as a
drug class and devices. The drug class is further segmented into insulin,
sensitizers, SGLT-2 inhibitors, alpha-glucosidase inhibitors, secretagogues,
peptide analogs, others. The sub-segment of sensitizers includes
thiazolidinediones and biguanides. The sub-segment of secretagogues includes
sulfonylureas and non-sulfonylureas. The devices market is further segmented
into blood glucose monitoring devices and insulin delivery devices. The
sub-segment of blood glucose monitoring devices includes testing strips, lancets,
continuous glucose monitors, self-monitoring blood glucose meters, and others.
The sub-segment of insulin delivery devices includes insulin pens, insulin
pumps, insulin syringes, and insulin jet injectors.
On the basis of the end user, the market is segmented into
hospitals, clinics, diagnostic centers, drug stores, pharmacies, and others.
Intended Audience:
·
Pharmaceutical Companies
·
Medical Device Companies
·
Research and Development (R&D) Companies
·
Diagnostic Laboratories
·
Government Research Institute
·
Academic Institutes and Universities
Research
Methodology:
Sources: National Institute of Neurological Disorders and
Stroke, United States Census Bureau, Age UK, Indian Brand Equity Foundation,
annual reports, press release, white paper, and company presentation
Regional
Analysis:
The Americas dominate the type 2 diabetes mellitus treatment
market owing to the presence of patient population, a well-developed
technology, high healthcare expenditure, and the presence of the leading
players. Due to the rising prevalence of diabetes, various companies, and
government associations are actively participating in improving diabetes care.
For instance, The Merck Foundation has provided funding of around USD
10,000,000 for the projects designed to improve diabetes care in the United
States. Asia Pacific is the fastest growing type 2 diabetes mellitus treatment
market owing to a huge patient pool, increasing demand, and development in
healthcare technology.
The Middle East & Africa holds the lowest share of the
global market due to low development, lack of technical knowledge, and poor
medical facilities.
Key players:
Some of key the players in the global type 2 diabetes
mellitus treatment market are Abbott Laboratories, Acon Laboratories, Inc.,
Adocia, Akros Pharma, Amgen, AstraZeneca, Bayer AG, Becton, Dickinson and
Company, Biocon, Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly, Merck,
Novartis & Co., Novo Nordisk, Peptron, Pfizer, Roche Diagnostics Ltd.,
Sanofi, Sunpharma, Takeda Pharmaceuticals, and others.
Get Your
Customized Report @https://www.marketresearchfuture.com/reports/type-2-diabetes-mellitus-treatment-market-5669
Table of
Content:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
TOC
Continued…!
About
US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone:
+1
646 845 9312
No comments:
Post a Comment